Oppenheimer Asset Management’s ARRIS International plc Ordinary Shares ARRS Stock Holding History

Oppenheimer Asset Management’s Portfolio ARRS Stock Details ARRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-64	Closed	-$2K	–	1683
2019 Q1	$2K	Sell	64 -9	-12%	-$282	﹤0.01%	1573
2018 Q4	$2K	Sell	73 -27,670	-100%	-$769K	﹤0.01%	1602
2018 Q3	$721K	Buy	27,743 +1,085	+4%	+$27.7K	0.02%	709
2018 Q2	$652K	Buy	26,658 +958	+4%	+$25.2K	0.02%	716
2018 Q1	$683K	Buy	25,700 +3,001	+13%	+$77.5K	0.02%	696
2017 Q4	$647K	Hold	22,699	–	–	0.02%	719
2017 Q3	$647K	Sell	22,699 -8,900	-28%	-$246K	0.02%	723
2017 Q2	$885K	Buy	31,599 +346	+1%	+$9.51K	0.02%	625
2017 Q1	$827K	Buy	+31,253	New	+$874K	0.02%	634

Other funds holding ARRS

McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return

PCG

Private Capital Group West Hartford, Connecticut $133M AUM 11.23% 1-Year Est. Return

Oppenheimer Asset Management's ARRS Position: Q2 2019 in Review

Oppenheimer Asset Management sold out of ARRIS International plc Ordinary Shares (ARRS) in Q2 2019, closing a stake of 64 shares — an estimated $2K sold.

Oppenheimer Asset Management first reported a position in ARRS in Q1 2017 and held it in 9 quarters. The position peaked at $885K in Q2 2017. 2 funds tracked by Wall St. Rank hold ARRS as of Q2 2019.

Oppenheimer Asset Management reported no remaining ARRIS International plc Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Oppenheimer Asset Management sold 64 ARRIS International plc Ordinary Shares shares in Q2 2019, an estimated $2K.
Oppenheimer Asset Management first reported a position in ARRIS International plc Ordinary Shares in Q1 2017 and held it in 9 quarters.
Oppenheimer Asset Management's ARRIS International plc Ordinary Shares position peaked at $885K in Q2 2017.
2 funds tracked by Wall St. Rank held ARRIS International plc Ordinary Shares as of Q2 2019.

Based on Oppenheimer Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.